Skip to main content
NCBI home page
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 2004 Jan;58(1):59–64. doi: 10.1136/jech.58.1.59

Neighbourhood social participation and women's use of anxiolytic-hypnotic drugs: a multilevel analysis

K Johnell 1, J Merlo 1, J Lynch 1, G Blennow 1
PMCID: PMC1757021  PMID: 14684728

Abstract

Study objectives: To identify and quantify a hypothesised collective effect of the neighbourhood on individual use of anxiolytic-hypnotic drugs (AHD). To analyse the general impact of neighbourhood social participation on use of AHD, adjusting for individual characteristics.

Design: Cross sectional analysis performed by multilevel logistic regression with women at the first level and neighbourhoods at the second level.

Setting: Malmö (250 000 inhabitants), Sweden.

Participants:15 456 women aged 45 to 73, residing in 95 neighbourhoods in Malmö, who took part in the Malmö diet and cancer study (1991–1996).

Main results: The prevalence of AHD use was 5.5% in the study sample. Overall, 1.7% of the total individual differences in the propensity for using AHD were explained by the neighbourhood level. This percentage, however, differed between different individuals. Low level of social participation in the neighbourhood was associated with higher probability of AHD use (OR = 3.10 (95% CI 1.51 to 6.41)), independently of individual age, low social participation, low educational level, and living alone. This association was reduced (OR = 2.01 (95% CI 0.97 to 4.14)) after the additional accounting for individual disability pension, low self rated health, stress, and medication for somatic disorders.

Conclusions: The neighbourhood level of social participation seems to affect individual use of AHD, possibly through individual characteristics. However, neighbourhood boundaries play a minor part in understanding individual AHD use in the city of Malmö.

Full Text

The Full Text of this article is available as a PDF (259.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashton H., Golding J. F. Tranquillisers: prevalence, predictors and possible consequences. Data from a large United Kingdom survey. Br J Addict. 1989 May;84(5):541–546. doi: 10.1111/j.1360-0443.1989.tb00611.x. [DOI] [PubMed] [Google Scholar]
  2. Berglund G., Elmstähl S., Janzon L., Larsson S. A. The Malmo Diet and Cancer Study. Design and feasibility. J Intern Med. 1993 Jan;233(1):45–51. doi: 10.1111/j.1365-2796.1993.tb00647.x. [DOI] [PubMed] [Google Scholar]
  3. Berkman L. F. Assessing social networks and social support in epidemiologic studies. Rev Epidemiol Sante Publique. 1987;35(1):46–53. [PubMed] [Google Scholar]
  4. Capellà D. Descriptive tools and analysis. WHO Reg Publ Eur Ser. 1993;45:55–78. [PubMed] [Google Scholar]
  5. Groenewegen P. P., Leufkens H. G., Spreeuwenberg P., Worm W. Neighbourhood characteristics and use of benzodiazepines in The Netherlands. Soc Sci Med. 1999 Jun;48(12):1701–1711. doi: 10.1016/s0277-9536(99)00061-1. [DOI] [PubMed] [Google Scholar]
  6. Haaijer-Ruskamp F. M., Hemminki E. The social aspects of drug use. WHO Reg Publ Eur Ser. 1993;45:97–124. [PubMed] [Google Scholar]
  7. Hanson B. S., Ostergren P. O., Elmståhl S., Isacsson S. O., Ranstam J. Reliability and validity assessments of measures of social networks, social support and control--results from the Malmö Shoulder and Neck Study. Scand J Soc Med. 1997 Dec;25(4):249–257. doi: 10.1177/140349489702500407. [DOI] [PubMed] [Google Scholar]
  8. Imanaka Y., Araki S., Nobutomo K. Effects of patient health beliefs and satisfaction on compliance with medication regimens in ambulatory care at general hospitals. Nihon Eiseigaku Zasshi. 1993 Jun;48(2):601–611. doi: 10.1265/jjh.48.601. [DOI] [PubMed] [Google Scholar]
  9. Isacson D., Haglund B. Psychotropic drug use in a Swedish community--the importance of demographic and socioeconomic factors. Soc Sci Med. 1988;26(4):477–483. doi: 10.1016/0277-9536(88)90317-6. [DOI] [PubMed] [Google Scholar]
  10. Kaplan G. A. What is the role of the social environment in understanding inequalities in health? Ann N Y Acad Sci. 1999;896:116–119. doi: 10.1111/j.1749-6632.1999.tb08109.x. [DOI] [PubMed] [Google Scholar]
  11. Lindström Martin, Merlo Juan, Ostergren Per-Olof. Individual and neighbourhood determinants of social participation and social capital: a multilevel analysis of the city of Malmö, Sweden. Soc Sci Med. 2002 Jun;54(12):1779–1791. doi: 10.1016/s0277-9536(01)00147-2. [DOI] [PubMed] [Google Scholar]
  12. Manjer J., Carlsson S., Elmståhl S., Gullberg B., Janzon L., Lindström M., Mattisson I., Berglund G. The Malmö Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev. 2001 Dec;10(6):489–499. doi: 10.1097/00008469-200112000-00003. [DOI] [PubMed] [Google Scholar]
  13. Melander A., Henricson K., Stenberg P., Löwenhielm P., Malmvik J., Sternebring B., Kaij L., Bergdahl U. Anxiolytic-hypnotic drugs: relationships between prescribing, abuse and suicide. Eur J Clin Pharmacol. 1991;41(6):525–529. doi: 10.1007/BF00314979. [DOI] [PubMed] [Google Scholar]
  14. Merlo J., Berglund G., Wirfält E., Gullberg B., Hedblad B., Manjer J., Hovelius B., Janzon L., Hanson B. S., Ostergren P. O. Self-administered questionnaire compared with a personal diary for assessment of current use of hormone therapy: an analysis of 16,060 women. Am J Epidemiol. 2000 Oct 15;152(8):788–792. doi: 10.1093/aje/152.8.788. [DOI] [PubMed] [Google Scholar]
  15. Merlo J. Multilevel analytical approaches in social epidemiology: measures of health variation compared with traditional measures of association. J Epidemiol Community Health. 2003 Aug;57(8):550–552. doi: 10.1136/jech.57.8.550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Merlo Juan, Lynch John W., Yang Min, Lindström Martin, Ostergren Per Olof, Rasmusen Niels Kristian, Råstam Lennart. Effect of neighborhood social participation on individual use of hormone replacement therapy and antihypertensive medication: a multilevel analysis. Am J Epidemiol. 2003 May 1;157(9):774–783. doi: 10.1093/aje/kwg053. [DOI] [PubMed] [Google Scholar]
  17. Rice N., Leyland A. Multilevel models: applications to health data. J Health Serv Res Policy. 1996 Jul;1(3):154–164. doi: 10.1177/135581969600100307. [DOI] [PubMed] [Google Scholar]
  18. Ukoumunne O. C., Gulliford M. C., Chinn S., Sterne J. A., Burney P. G. Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. Health Technol Assess. 1999;3(5):iii–i92. [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES